कोविड-19 का टीका (Hindi Wikipedia)

Analysis of information sources in references of the Wikipedia article "कोविड-19 का टीका" in Hindi language version.

refsWebsite

Global rank Hindi rank

49web.archive.org

1^st place

25nih.gov

4^th place

7^th place

13doi.org

2^nd place

5^th place

6worldcat.org

5^th place

8^th place

6who.int

195^th place

72^nd place

4cepi.net

low place

2gatesnotes.com

low place

2nytimes.com

7^th place

49^th place

2canada.ca

1,712^th place

low place

2cdc.gov

218^th place

154^th place

1sciencealert.com

5,043^rd place

low place

1nature.com

234^th place

288^th place

1yahoo.com

38^th place

46^th place

1indiatimes.com

17^th place

3^rd place

1thelancet.com

2,393^rd place

4,433^rd place

1reuters.com

49^th place

168^th place

1businessinsider.com

140^th place

977^th place

1gavi.org

low place

1glopid-r.org

low place

1tghn.org

low place

1globalnews.ca

985^th place

8,885^th place

1ctvnews.ca

768^th place

8,697^th place

1nikkei.com

211^th place

6,008^th place

1europa.eu

68^th place

137^th place

1pharmafield.co.uk

low place

1telegraph.co.uk

30^th place

79^th place

1ox.ac.uk

613^th place

685^th place

1cnn.com

28^th place

139^th place

1nbcnews.com

137^th place

1,251^st place

1fda.gov

447^th place

1,057^th place

1pharmanewsintel.com

low place

1shinyapps.io

low place

1docs.google.com

1,047^th place

2,570^th place

1milkeninstitute.org

low place

1bio.org

low place

1fiercepharma.com

low place

1hra.nhs.uk

low place

1clinicaltrialsregister.eu

low place

1swr.de

1,755^th place

low place

1clinicaltrials.gov

5,225^th place

9,959^th place

1ivi.int

low place

1chictr.org.cn

low place

1the-scientist.com

7,827^th place

low place

1thestar.com

336^th place

3,571^st place

1nhs.uk

1,989^th place

2,427^th place

1politifact.com

3,208^th place

low place

1factcheck.org

7,075^th place

4,414^th place

bio.org

"Clinical Development Success Rates 2006-2015" (PDF). BIO Industry Analysis. June 2016. मूल से 12 सितंबर 2019 को पुरालेखित (PDF). अभिगमन तिथि 18 मई 2020.

businessinsider.com

Hamilton, Isobel Asher (2020-05-01). "Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates and one could be ready in as little as 9 months". Business Insider. मूल से 16 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.

canada.ca

"Government of Canada's research response to COVID-19". Government of Canada. 2020-04-23. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-04.
"Government of Canada funds 49 additional COVID-19 research projects – Details of the funded projects". Government of Canada. 23 March 2020. मूल से 22 मार्च 2020 को पुरालेखित. अभिगमन तिथि 23 March 2020.

cdc.gov

"How flu vaccine effectiveness and efficacy are measured". Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, US Department of Health and Human Services. 2016-01-29. मूल से 7 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.
"Principles of epidemiology, Section 8: Concepts of disease occurrence". Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services, US Department of Health and Human Services. 2012-05-18. मूल से 6 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.

cepi.net

"CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19". Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 6 March 2020. मूल से 22 मार्च 2020 को पुरालेखित. अभिगमन तिथि 23 March 2020.
"Landmark global collaboration launched to defeat COVID-19 pandemic". CEPI. 2020-04-24. मूल से 2 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02. The global nature of a pandemic means that any vaccine or medicine that is successfully developed will be needed immediately all over the world. That means that the challenge we face is not only one of R&D but one of manufacturing at scale, and equitable access.
"CEPI: Our vaccine and platform portfolio". Coalition for Epidemic Preparedness Innovation (CEPI). 2020-04-30. मूल से 7 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.
"CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine". Coalition for Epidemic Preparedness Innovations. 19 March 2020. मूल से 22 मार्च 2020 को पुरालेखित. अभिगमन तिथि 23 March 2020.

chictr.org.cn

"A randomized, double-blind, placebo parallel-controlled phase I/II clinical trial for inactivated novel coronavirus pneumonia vaccine (vero cells)". Chinese Clinical Trial Registry. 2020-04-11. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-04-25.

clinicaltrials.gov

"Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) - Full Text View - ClinicalTrials.gov". clinicaltrials.gov (अंग्रेज़ी में). US National Library of Medicine, National Institutes of Health. अभिगमन तिथि 13 May 2020.

clinicaltrialsregister.eu

"EudraCT Number 2020-001038-36". EU Clinical Trials Register. European Union. मूल से 22 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 22 April 2020.

cnn.com

Kuznia, Robert; Polglase, Katie; Mezzofiore, Gianluca (2020-05-01). "In quest for vaccine, US makes 'big bet' on company with unproven technology". CNN. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.

ctvnews.ca

Aiello, Rachel (2020-05-04). "'A global challenge': PM Trudeau commits $850 million to global fight against COVID-19". CTV News. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-04.

docs.google.com

"COVID-19 vaccine tracker (Choose vaccines tab; updated 2-3x/week)". Milken Institute. 2020-05-12. मूल से 8 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-15. सहज सारांश.

doi.org

Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 April 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. PMID 32273591. आइ॰एस॰एस॰एन॰ 1474-1776. डीओआइ:10.1038/d41573-020-00073-5. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 18 मई 2020. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "thanh" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Gates B (February 2020). "Responding to Covid-19: A once-in-a-century pandemic?". The New England Journal of Medicine. 382 (18): 1677–1679. PMID 32109012. डीओआइ:10.1056/nejmp2003762.
Fauci AS, Lane HC, Redfield RR (March 2020). "Covid-19: Navigating the uncharted". The New England Journal of Medicine. 382 (13): 1268–1269. PMID 32109011. डीओआइ:10.1056/nejme2002387. पी॰एम॰सी॰ 7121221 |pmc= के मान की जाँच करें (मदद).
Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, एवं अन्य (February 2018). "Adaptive designs in clinical trials: why use them, and how to run and report them". BMC Medicine. 16 (1): 29. PMID 29490655. डीओआइ:10.1186/s12916-018-1017-7. पी॰एम॰सी॰ 5830330.
Simpson, Shmona; Kaufmann, Michael C.; Glozman, Vitaly; Chakrabarti, Ajoy (May 2020). "Disease X: accelerating the development of medical countermeasures for the next pandemic". The Lancet. Infectious Diseases. 20 (5): e108–e115. PMID 32197097. आइ॰एस॰एस॰एन॰ 1474-4457. डीओआइ:10.1016/S1473-3099(20)30123-7. पी॰एम॰सी॰ 7158580 |pmc= के मान की जाँच करें (मदद).
Wiedermann, Ursula; Garner-Spitzer, Erika; Wagner, Angelika (2016). "Primary vaccine failure to routine vaccines: Why and what to do?". Human Vaccines and Immunotherapeutics. 12 (1): 239–243. PMID 26836329. आइ॰एस॰एस॰एन॰ 2164-554X. डीओआइ:10.1080/21645515.2015.1093263. पी॰एम॰सी॰ 4962729.
Cavanagh D (December 2003). "Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus". Avian Pathology. 32 (6): 567–82. PMID 14676007. डीओआइ:10.1080/03079450310001621198. पी॰एम॰सी॰ 7154303 |pmc= के मान की जाँच करें (मदद).
Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD, एवं अन्य (December 2003). "Effects of a SARS-associated coronavirus vaccine in monkeys". Lancet. 362 (9399): 1895–6. PMID 14667748. डीओआइ:10.1016/S0140-6736(03)14962-8. पी॰एम॰सी॰ 7112457 |pmc= के मान की जाँच करें (मदद).
Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, एवं अन्य (October 2014). "Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice". Vaccine. 32 (45): 5975–82. PMID 25192975. डीओआइ:10.1016/j.vaccine.2014.08.058. पी॰एम॰सी॰ 7115510 |pmc= के मान की जाँच करें (मदद).
Jiang S, Lu L, Du L (January 2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology. 8 (1): 1–2. PMID 32201503. डीओआइ:10.2217/fvl.12.126. पी॰एम॰सी॰ 7079997 |pmc= के मान की जाँच करें (मदद).
Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, एवं अन्य (February 2005). "Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice". The Journal of Infectious Diseases. 191 (4): 507–14. PMID 15655773. डीओआइ:10.1086/427242. पी॰एम॰सी॰ 7110081 |pmc= के मान की जाँच करें (मदद).
Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, एवं अन्य (September 2005). "Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins". Journal of Virological Methods. 128 (1–2): 21–8. PMID 15885812. डीओआइ:10.1016/j.jviromet.2005.03.021. पी॰एम॰सी॰ 7112802 |pmc= के मान की जाँच करें (मदद).
Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, एवं अन्य (March 2006). "Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters". The Journal of Infectious Diseases. 193 (5): 685–92. PMID 16453264. डीओआइ:10.1086/500143. पी॰एम॰सी॰ 7109703 |pmc= के मान की जाँच करें (मदद).

europa.eu

ec.europa.eu

"Coronavirus: Commission offers financing to innovative vaccines company CureVac". European Commission. 16 March 2020. मूल से 19 मार्च 2020 को पुरालेखित. अभिगमन तिथि 19 March 2020.

factcheck.org

McDonald, Jessica (24 January 2020). "Social Media Posts Spread Bogus Coronavirus Conspiracy Theory". FactCheck.org. Annenberg Public Policy Center. मूल से 6 February 2020 को पुरालेखित. अभिगमन तिथि 8 February 2020.

fda.gov

"Adaptive designs for clinical trials of drugs and biologics: Guidance for industry". US Food and Drug Administration. 1 November 2019. मूल से 13 दिसंबर 2019 को पुरालेखित. अभिगमन तिथि 3 April 2020.

fiercepharma.com

Angus Liu (2020-04-10). "China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data". FiercePharma (अंग्रेज़ी में). मूल से 2020-04-30 को पुरालेखित. अभिगमन तिथि 2020-04-13. 'CanSino and its collaborators at the Academy of Military Medical Sciences' Institute of Biotechnology plan to move their adenovirus type-5 vector-based recombinant COVID-19 vaccine, Ad5-nCoV, into phase 2 clinical trial in China "soon",' the company said in a disclosure (PDF) to the Hong Kong Stock Exchange on Thursday.

gatesnotes.com

Gates, Bill (2020-04-30). "The vaccine race explained: What you need to know about the COVID-19 vaccine". The Gates Notes. मूल से 14 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Gates, Bill (2020-04-23). "The first modern pandemic: The scientific advances we need to stop COVID-19". The Gates Notes. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.

gavi.org

"COVID-19: Gavi steps up response to pandemic". gavi.org. 2020-04-27. मूल से 27 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.

globalnews.ca

Abedi, Maham (23 March 2020). "Canada to spend $192M on developing COVID-19 vaccine". Global News. मूल से 9 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 24 March 2020.

glopid-r.org

"GloPID: Novel coronavirus COVID-19". glopid-r.org. मूल से 2 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.

hra.nhs.uk

"A phase I/II study to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers" (अंग्रेज़ी में). Health Research Authority, UK National Health Service. मूल से 18 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-10.

indiatimes.com

navbharattimes.indiatimes.com

"Coronavirus Vaccine Live News Update: ब्रिटेन में लगने लगी कोरोना वायरस वैक्‍सीन, 90 साल की दादी को लगा पहला टीका". Navbharat Times. अभिगमन तिथि 2020-12-08.

ivi.int

"IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO's COVID-19 DNA vaccine in South Korea". International Vaccine Institute. 2020-04-16. अभिगमन तिथि 2020-04-23.

milkeninstitute.org

"COVID-19 vaccine tracker (Choose vaccines tab; updated 2-3x/week)". Milken Institute. 2020-05-12. मूल से 8 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-15. सहज सारांश.

nature.com

Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 April 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. PMID 32273591. आइ॰एस॰एस॰एन॰ 1474-1776. डीओआइ:10.1038/d41573-020-00073-5. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 18 मई 2020. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "thanh" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है

nbcnews.com

Lee, Carol E; Welker, Kristen; Perlmutter-Gumbiner, Elyse (2020-05-01). "Health officials eyeing at least one of 14 potential coronavirus vaccines to fast-track". NBC News. मूल से 11 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.

nhs.uk

"SARS (severe acute respiratory syndrome)". National Health Service. 5 March 2020. मूल से 9 March 2020 को पुरालेखित. अभिगमन तिथि 31 January 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 April 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. PMID 32273591. आइ॰एस॰एस॰एन॰ 1474-1776. डीओआइ:10.1038/d41573-020-00073-5. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 18 मई 2020. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "thanh" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Gates B (February 2020). "Responding to Covid-19: A once-in-a-century pandemic?". The New England Journal of Medicine. 382 (18): 1677–1679. PMID 32109012. डीओआइ:10.1056/nejmp2003762.
Fauci AS, Lane HC, Redfield RR (March 2020). "Covid-19: Navigating the uncharted". The New England Journal of Medicine. 382 (13): 1268–1269. PMID 32109011. डीओआइ:10.1056/nejme2002387. पी॰एम॰सी॰ 7121221 |pmc= के मान की जाँच करें (मदद).
Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, एवं अन्य (February 2018). "Adaptive designs in clinical trials: why use them, and how to run and report them". BMC Medicine. 16 (1): 29. PMID 29490655. डीओआइ:10.1186/s12916-018-1017-7. पी॰एम॰सी॰ 5830330.
Simpson, Shmona; Kaufmann, Michael C.; Glozman, Vitaly; Chakrabarti, Ajoy (May 2020). "Disease X: accelerating the development of medical countermeasures for the next pandemic". The Lancet. Infectious Diseases. 20 (5): e108–e115. PMID 32197097. आइ॰एस॰एस॰एन॰ 1474-4457. डीओआइ:10.1016/S1473-3099(20)30123-7. पी॰एम॰सी॰ 7158580 |pmc= के मान की जाँच करें (मदद).
Wiedermann, Ursula; Garner-Spitzer, Erika; Wagner, Angelika (2016). "Primary vaccine failure to routine vaccines: Why and what to do?". Human Vaccines and Immunotherapeutics. 12 (1): 239–243. PMID 26836329. आइ॰एस॰एस॰एन॰ 2164-554X. डीओआइ:10.1080/21645515.2015.1093263. पी॰एम॰सी॰ 4962729.
Cavanagh D (December 2003). "Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus". Avian Pathology. 32 (6): 567–82. PMID 14676007. डीओआइ:10.1080/03079450310001621198. पी॰एम॰सी॰ 7154303 |pmc= के मान की जाँच करें (मदद).
Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD, एवं अन्य (December 2003). "Effects of a SARS-associated coronavirus vaccine in monkeys". Lancet. 362 (9399): 1895–6. PMID 14667748. डीओआइ:10.1016/S0140-6736(03)14962-8. पी॰एम॰सी॰ 7112457 |pmc= के मान की जाँच करें (मदद).
Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, एवं अन्य (October 2014). "Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice". Vaccine. 32 (45): 5975–82. PMID 25192975. डीओआइ:10.1016/j.vaccine.2014.08.058. पी॰एम॰सी॰ 7115510 |pmc= के मान की जाँच करें (मदद).
Jiang S, Lu L, Du L (January 2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology. 8 (1): 1–2. PMID 32201503. डीओआइ:10.2217/fvl.12.126. पी॰एम॰सी॰ 7079997 |pmc= के मान की जाँच करें (मदद).
Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, एवं अन्य (February 2005). "Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice". The Journal of Infectious Diseases. 191 (4): 507–14. PMID 15655773. डीओआइ:10.1086/427242. पी॰एम॰सी॰ 7110081 |pmc= के मान की जाँच करें (मदद).
Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, एवं अन्य (September 2005). "Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins". Journal of Virological Methods. 128 (1–2): 21–8. PMID 15885812. डीओआइ:10.1016/j.jviromet.2005.03.021. पी॰एम॰सी॰ 7112802 |pmc= के मान की जाँच करें (मदद).
Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, एवं अन्य (March 2006). "Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters". The Journal of Infectious Diseases. 193 (5): 685–92. PMID 16453264. डीओआइ:10.1086/500143. पी॰एम॰सी॰ 7109703 |pmc= के मान की जाँच करें (मदद).

ncbi.nlm.nih.gov

Fauci AS, Lane HC, Redfield RR (March 2020). "Covid-19: Navigating the uncharted". The New England Journal of Medicine. 382 (13): 1268–1269. PMID 32109011. डीओआइ:10.1056/nejme2002387. पी॰एम॰सी॰ 7121221 |pmc= के मान की जाँच करें (मदद).
Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, एवं अन्य (February 2018). "Adaptive designs in clinical trials: why use them, and how to run and report them". BMC Medicine. 16 (1): 29. PMID 29490655. डीओआइ:10.1186/s12916-018-1017-7. पी॰एम॰सी॰ 5830330.
Simpson, Shmona; Kaufmann, Michael C.; Glozman, Vitaly; Chakrabarti, Ajoy (May 2020). "Disease X: accelerating the development of medical countermeasures for the next pandemic". The Lancet. Infectious Diseases. 20 (5): e108–e115. PMID 32197097. आइ॰एस॰एस॰एन॰ 1474-4457. डीओआइ:10.1016/S1473-3099(20)30123-7. पी॰एम॰सी॰ 7158580 |pmc= के मान की जाँच करें (मदद).
Wiedermann, Ursula; Garner-Spitzer, Erika; Wagner, Angelika (2016). "Primary vaccine failure to routine vaccines: Why and what to do?". Human Vaccines and Immunotherapeutics. 12 (1): 239–243. PMID 26836329. आइ॰एस॰एस॰एन॰ 2164-554X. डीओआइ:10.1080/21645515.2015.1093263. पी॰एम॰सी॰ 4962729.
Cavanagh D (December 2003). "Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus". Avian Pathology. 32 (6): 567–82. PMID 14676007. डीओआइ:10.1080/03079450310001621198. पी॰एम॰सी॰ 7154303 |pmc= के मान की जाँच करें (मदद).
Gao W, Tamin A, Soloff A, D'Aiuto L, Nwanegbo E, Robbins PD, एवं अन्य (December 2003). "Effects of a SARS-associated coronavirus vaccine in monkeys". Lancet. 362 (9399): 1895–6. PMID 14667748. डीओआइ:10.1016/S0140-6736(03)14962-8. पी॰एम॰सी॰ 7112457 |pmc= के मान की जाँच करें (मदद).
Kim E, Okada K, Kenniston T, Raj VS, AlHajri MM, Farag EA, एवं अन्य (October 2014). "Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice". Vaccine. 32 (45): 5975–82. PMID 25192975. डीओआइ:10.1016/j.vaccine.2014.08.058. पी॰एम॰सी॰ 7115510 |pmc= के मान की जाँच करें (मदद).
Jiang S, Lu L, Du L (January 2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology. 8 (1): 1–2. PMID 32201503. डीओआइ:10.2217/fvl.12.126. पी॰एम॰सी॰ 7079997 |pmc= के मान की जाँच करें (मदद).
Greenough TC, Babcock GJ, Roberts A, Hernandez HJ, Thomas WD, Coccia JA, एवं अन्य (February 2005). "Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice". The Journal of Infectious Diseases. 191 (4): 507–14. PMID 15655773. डीओआइ:10.1086/427242. पी॰एम॰सी॰ 7110081 |pmc= के मान की जाँच करें (मदद).
Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, एवं अन्य (September 2005). "Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins". Journal of Virological Methods. 128 (1–2): 21–8. PMID 15885812. डीओआइ:10.1016/j.jviromet.2005.03.021. पी॰एम॰सी॰ 7112802 |pmc= के मान की जाँच करें (मदद).
Roberts A, Thomas WD, Guarner J, Lamirande EW, Babcock GJ, Greenough TC, एवं अन्य (March 2006). "Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters". The Journal of Infectious Diseases. 193 (5): 685–92. PMID 16453264. डीओआइ:10.1086/500143. पी॰एम॰सी॰ 7109703 |pmc= के मान की जाँच करें (मदद).

nih.gov

"NIH clinical trial of investigational vaccine for COVID-19 begins". US National Institutes of Health. 16 March 2020. मूल से 19 मार्च 2020 को पुरालेखित. अभिगमन तिथि 17 March 2020.

nikkei.com

asia.nikkei.com

Takada, Noriyuki; Satake, Minoru (2020-05-02). "US and China unleash wallets in race for coronavirus vaccine". Nikkei Asian Review. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.

nytimes.com

Sanger, David E.; Kirkpatrick, David D.; Zimmer, Carl; Thomas, Katie; Wee, Sui-Lee (2020-05-02). "With Pressure Growing, Global Race for a Vaccine Intensifies". The New York Times. आइ॰एस॰एस॰एन॰ 0362-4331. मूल से 11 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Stevis-Gridneff, Matina; Jakes, Lara (2020-05-04). "World Leaders Join to Pledge $8 Billion for Vaccine as U.S. Goes It Alone". The New York Times (अंग्रेज़ी में). आइ॰एस॰एस॰एन॰ 0362-4331. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-10.

ox.ac.uk

"Landmark partnership announced for development of COVID-19 vaccine". University of Oxford. 2020-04-30. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.

pharmafield.co.uk

Morriss, Emma (2020-04-22). "Government launches coronavirus vaccine taskforce as human clinical trials start". Pharmafield. अभिगमन तिथि 2020-05-03.

pharmanewsintel.com

McGrail, Samantha (2020-04-15). "Sanofi, GSK partner to develop adjuvanted COVID-19 vaccine". PharmaNewsIntelligence. मूल से 9 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-04.

politifact.com

Kertscher, Tom (23 January 2020). "No, there is no vaccine for the Wuhan coronavirus". PolitiFact. Poynter Institute. मूल से 7 February 2020 को पुरालेखित. अभिगमन तिथि 7 February 2020.

reuters.com

Julie Steenhuysen; Peter Eisler; Allison Martell; Stephanie Nebehay (2020-04-27). "Special Report: Countries, companies risk billions in race for coronavirus vaccine". Reuters. मूल से 15 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.

sciencealert.com

Grenfell, Rob; Drew, Trevor (17 February 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". ScienceAlert. मूल से 28 February 2020 को पुरालेखित. अभिगमन तिथि 26 February 2020.

shinyapps.io

vac-lshtm.shinyapps.io

"COVID-19 vaccine development pipeline (Refresh URL to update)". Vaccine Centre, London School of Hygiene and Tropical Medicine. 2020-05-11. मूल से 18 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-14.

swr.de

"Mainzer Unternehmen Biontech testet Corona-Impfstoff". swr.online (जर्मन में). SWR. 22 April 2020. मूल से 21 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 22 April 2020.

telegraph.co.uk

Gartner, Annelies; Roberts, Lizzie (2020-05-03). "How close are we to a coronavirus vaccine? Latest news on UK trials". The Telegraph. आइ॰एस॰एस॰एन॰ 0307-1235. मूल से 4 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.

tghn.org

isaric.tghn.org

"ISARIC: COVID-19 clinical research resources". ISARIC. 2020-04-27. मूल से 30 मार्च 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.

the-scientist.com

Jef Akst (2020-04-29). "COVID-19 vaccine frontrunners". The Scientist Magazine. मूल से 6 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-04-30.

thelancet.com

Gavin Yamey, Marco Schäferhoff, Richard Hatchett, Muhammad Pate, Feng Zhao, Kaci Kennedy McDade (2020-05-02). "Ensuring global access to COVID-19 vaccines" (PDF). The Lancet. 305: 1405–6. CEPI estimates that developing up to three vaccines in the next 12–18 months will require an investment of at least US$2 billion. This estimate includes phase 1 clinical trials of eight vaccine candidates, progression of up to six candidates through phase 2 and 3 trials, completion of regulatory and quality requirements for at least three vaccines, and enhancing global manufacturing capacity for three vaccines. |quote= में 240 स्थान पर line feed character (मदद)सीएस1 रखरखाव: एक से अधिक नाम: authors list (link)

thestar.com

Blanchfield, Mike (2020-04-30). "Global philanthropists, experts call for COVID-19 vaccine distribution plan". The Toronto Star. मूल से 7 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.

web.archive.org

Grenfell, Rob; Drew, Trevor (17 February 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". ScienceAlert. मूल से 28 February 2020 को पुरालेखित. अभिगमन तिथि 26 February 2020.
"CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19". Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 6 March 2020. मूल से 22 मार्च 2020 को पुरालेखित. अभिगमन तिथि 23 March 2020.
Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 April 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. PMID 32273591. आइ॰एस॰एस॰एन॰ 1474-1776. डीओआइ:10.1038/d41573-020-00073-5. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 18 मई 2020. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "thanh" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
"Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine". World Health Organization. 2020-04-27. मूल से 30 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02. It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale
"World Health Organization timeline - COVID-19". World Health Organization. 2020-04-27. मूल से 29 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Gates, Bill (2020-04-30). "The vaccine race explained: What you need to know about the COVID-19 vaccine". The Gates Notes. मूल से 14 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Sanger, David E.; Kirkpatrick, David D.; Zimmer, Carl; Thomas, Katie; Wee, Sui-Lee (2020-05-02). "With Pressure Growing, Global Race for a Vaccine Intensifies". The New York Times. आइ॰एस॰एस॰एन॰ 0362-4331. मूल से 11 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"Commitment and call to action: Global collaboration to accelerate new COVID-19 health technologies". World Health Organization. 2020-04-24. मूल से 12 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"Landmark global collaboration launched to defeat COVID-19 pandemic". CEPI. 2020-04-24. मूल से 2 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02. The global nature of a pandemic means that any vaccine or medicine that is successfully developed will be needed immediately all over the world. That means that the challenge we face is not only one of R&D but one of manufacturing at scale, and equitable access.
Julie Steenhuysen; Peter Eisler; Allison Martell; Stephanie Nebehay (2020-04-27). "Special Report: Countries, companies risk billions in race for coronavirus vaccine". Reuters. मूल से 15 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Hamilton, Isobel Asher (2020-05-01). "Bill Gates thinks there are 8 to 10 promising coronavirus vaccine candidates and one could be ready in as little as 9 months". Business Insider. मूल से 16 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"COVID-19: Gavi steps up response to pandemic". gavi.org. 2020-04-27. मूल से 27 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"GloPID: Novel coronavirus COVID-19". glopid-r.org. मूल से 2 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"Government of Canada's research response to COVID-19". Government of Canada. 2020-04-23. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-04.
"ISARIC: COVID-19 clinical research resources". ISARIC. 2020-04-27. मूल से 30 मार्च 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Abedi, Maham (23 March 2020). "Canada to spend $192M on developing COVID-19 vaccine". Global News. मूल से 9 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 24 March 2020.
"Government of Canada funds 49 additional COVID-19 research projects – Details of the funded projects". Government of Canada. 23 March 2020. मूल से 22 मार्च 2020 को पुरालेखित. अभिगमन तिथि 23 March 2020.
Aiello, Rachel (2020-05-04). "'A global challenge': PM Trudeau commits $850 million to global fight against COVID-19". CTV News. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-04.
Takada, Noriyuki; Satake, Minoru (2020-05-02). "US and China unleash wallets in race for coronavirus vaccine". Nikkei Asian Review. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.
"CEPI: Our vaccine and platform portfolio". Coalition for Epidemic Preparedness Innovation (CEPI). 2020-04-30. मूल से 7 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.
"CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine". Coalition for Epidemic Preparedness Innovations. 19 March 2020. मूल से 22 मार्च 2020 को पुरालेखित. अभिगमन तिथि 23 March 2020.
"Coronavirus: Commission offers financing to innovative vaccines company CureVac". European Commission. 16 March 2020. मूल से 19 मार्च 2020 को पुरालेखित. अभिगमन तिथि 19 March 2020.
Gartner, Annelies; Roberts, Lizzie (2020-05-03). "How close are we to a coronavirus vaccine? Latest news on UK trials". The Telegraph. आइ॰एस॰एस॰एन॰ 0307-1235. मूल से 4 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.
"Landmark partnership announced for development of COVID-19 vaccine". University of Oxford. 2020-04-30. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.
Kuznia, Robert; Polglase, Katie; Mezzofiore, Gianluca (2020-05-01). "In quest for vaccine, US makes 'big bet' on company with unproven technology". CNN. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Lee, Carol E; Welker, Kristen; Perlmutter-Gumbiner, Elyse (2020-05-01). "Health officials eyeing at least one of 14 potential coronavirus vaccines to fast-track". NBC News. मूल से 11 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"Draft landscape of COVID 19 candidate vaccines". World Health Organization. 2020-05-05. मूल से 14 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-09.
"An international randomised trial of candidate vaccines against COVID-19: Outline of Solidarity vaccine trial" (PDF). World Health Organization. 2020-04-09. मूल से 12 मई 2020 को पुरालेखित (PDF). अभिगमन तिथि 2020-05-09.
"Adaptive designs for clinical trials of drugs and biologics: Guidance for industry". US Food and Drug Administration. 1 November 2019. मूल से 13 दिसंबर 2019 को पुरालेखित. अभिगमन तिथि 3 April 2020.
McGrail, Samantha (2020-04-15). "Sanofi, GSK partner to develop adjuvanted COVID-19 vaccine". PharmaNewsIntelligence. मूल से 9 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-04.
"COVID-19 vaccine development pipeline (Refresh URL to update)". Vaccine Centre, London School of Hygiene and Tropical Medicine. 2020-05-11. मूल से 18 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-14.
"COVID-19 vaccine tracker (Choose vaccines tab; updated 2-3x/week)". Milken Institute. 2020-05-12. मूल से 8 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-15. सहज सारांश.
"Clinical Development Success Rates 2006-2015" (PDF). BIO Industry Analysis. June 2016. मूल से 12 सितंबर 2019 को पुरालेखित (PDF). अभिगमन तिथि 18 मई 2020.
Angus Liu (2020-04-10). "China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data". FiercePharma (अंग्रेज़ी में). मूल से 2020-04-30 को पुरालेखित. अभिगमन तिथि 2020-04-13. 'CanSino and its collaborators at the Academy of Military Medical Sciences' Institute of Biotechnology plan to move their adenovirus type-5 vector-based recombinant COVID-19 vaccine, Ad5-nCoV, into phase 2 clinical trial in China "soon",' the company said in a disclosure (PDF) to the Hong Kong Stock Exchange on Thursday.
"A phase I/II study to determine efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers" (अंग्रेज़ी में). Health Research Authority, UK National Health Service. मूल से 18 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-10.
"EudraCT Number 2020-001038-36". EU Clinical Trials Register. European Union. मूल से 22 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 22 April 2020.
"Mainzer Unternehmen Biontech testet Corona-Impfstoff". swr.online (जर्मन में). SWR. 22 April 2020. मूल से 21 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 22 April 2020.
"NIH clinical trial of investigational vaccine for COVID-19 begins". US National Institutes of Health. 16 March 2020. मूल से 19 मार्च 2020 को पुरालेखित. अभिगमन तिथि 17 March 2020.
"A randomized, double-blind, placebo parallel-controlled phase I/II clinical trial for inactivated novel coronavirus pneumonia vaccine (vero cells)". Chinese Clinical Trial Registry. 2020-04-11. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-04-25.
"Draft landscape of COVID-19 candidate vaccines – 23 April 2020" (PDF). World Health Organization. 2020-04-23. मूल से 16 मई 2020 को पुरालेखित (PDF). अभिगमन तिथि 2020-04-25.
Jef Akst (2020-04-29). "COVID-19 vaccine frontrunners". The Scientist Magazine. मूल से 6 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-04-30.
"How flu vaccine effectiveness and efficacy are measured". Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, US Department of Health and Human Services. 2016-01-29. मूल से 7 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.
"Principles of epidemiology, Section 8: Concepts of disease occurrence". Centers for Disease Control and Prevention, Center for Surveillance, Epidemiology, and Laboratory Services, US Department of Health and Human Services. 2012-05-18. मूल से 6 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.
Gates, Bill (2020-04-23). "The first modern pandemic: The scientific advances we need to stop COVID-19". The Gates Notes. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.
Stevis-Gridneff, Matina; Jakes, Lara (2020-05-04). "World Leaders Join to Pledge $8 Billion for Vaccine as U.S. Goes It Alone". The New York Times (अंग्रेज़ी में). आइ॰एस॰एस॰एन॰ 0362-4331. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-10.
Blanchfield, Mike (2020-04-30). "Global philanthropists, experts call for COVID-19 vaccine distribution plan". The Toronto Star. मूल से 7 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-06.
"SARS (severe acute respiratory syndrome)". National Health Service. 5 March 2020. मूल से 9 March 2020 को पुरालेखित. अभिगमन तिथि 31 January 2020.
Kertscher, Tom (23 January 2020). "No, there is no vaccine for the Wuhan coronavirus". PolitiFact. Poynter Institute. मूल से 7 February 2020 को पुरालेखित. अभिगमन तिथि 7 February 2020.
McDonald, Jessica (24 January 2020). "Social Media Posts Spread Bogus Coronavirus Conspiracy Theory". FactCheck.org. Annenberg Public Policy Center. मूल से 6 February 2020 को पुरालेखित. अभिगमन तिथि 8 February 2020.

who.int

"Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine". World Health Organization. 2020-04-27. मूल से 30 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02. It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale
"World Health Organization timeline - COVID-19". World Health Organization. 2020-04-27. मूल से 29 अप्रैल 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"Commitment and call to action: Global collaboration to accelerate new COVID-19 health technologies". World Health Organization. 2020-04-24. मूल से 12 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
"Draft landscape of COVID 19 candidate vaccines". World Health Organization. 2020-05-05. मूल से 14 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-09.
"An international randomised trial of candidate vaccines against COVID-19: Outline of Solidarity vaccine trial" (PDF). World Health Organization. 2020-04-09. मूल से 12 मई 2020 को पुरालेखित (PDF). अभिगमन तिथि 2020-05-09.
"Draft landscape of COVID-19 candidate vaccines – 23 April 2020" (PDF). World Health Organization. 2020-04-23. मूल से 16 मई 2020 को पुरालेखित (PDF). अभिगमन तिथि 2020-04-25.

worldcat.org

Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 April 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. PMID 32273591. आइ॰एस॰एस॰एन॰ 1474-1776. डीओआइ:10.1038/d41573-020-00073-5. मूल से 10 मई 2020 को पुरालेखित. अभिगमन तिथि 18 मई 2020. सन्दर्भ त्रुटि: <ref> अमान्य टैग है; "thanh" नाम कई बार विभिन्न सामग्रियों में परिभाषित हो चुका है
Sanger, David E.; Kirkpatrick, David D.; Zimmer, Carl; Thomas, Katie; Wee, Sui-Lee (2020-05-02). "With Pressure Growing, Global Race for a Vaccine Intensifies". The New York Times. आइ॰एस॰एस॰एन॰ 0362-4331. मूल से 11 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-02.
Gartner, Annelies; Roberts, Lizzie (2020-05-03). "How close are we to a coronavirus vaccine? Latest news on UK trials". The Telegraph. आइ॰एस॰एस॰एन॰ 0307-1235. मूल से 4 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-03.
Simpson, Shmona; Kaufmann, Michael C.; Glozman, Vitaly; Chakrabarti, Ajoy (May 2020). "Disease X: accelerating the development of medical countermeasures for the next pandemic". The Lancet. Infectious Diseases. 20 (5): e108–e115. PMID 32197097. आइ॰एस॰एस॰एन॰ 1474-4457. डीओआइ:10.1016/S1473-3099(20)30123-7. पी॰एम॰सी॰ 7158580 |pmc= के मान की जाँच करें (मदद).
Wiedermann, Ursula; Garner-Spitzer, Erika; Wagner, Angelika (2016). "Primary vaccine failure to routine vaccines: Why and what to do?". Human Vaccines and Immunotherapeutics. 12 (1): 239–243. PMID 26836329. आइ॰एस॰एस॰एन॰ 2164-554X. डीओआइ:10.1080/21645515.2015.1093263. पी॰एम॰सी॰ 4962729.
Stevis-Gridneff, Matina; Jakes, Lara (2020-05-04). "World Leaders Join to Pledge $8 Billion for Vaccine as U.S. Goes It Alone". The New York Times (अंग्रेज़ी में). आइ॰एस॰एस॰एन॰ 0362-4331. मूल से 13 मई 2020 को पुरालेखित. अभिगमन तिथि 2020-05-10.

yahoo.com

finance.yahoo.com

Damon Wake (2020-05-04). "World leaders urge cooperation in vaccine hunt, raise $8 billion". Yahoo Finance. अभिगमन तिथि 2020-05-04.